01 1BrightGene Bio-Medical Technology Co.,Ltd
01 12-[(1S,2S)-1-ETHY1-2-BEZYLOXYPROPYL]-2,4-DIHYDRO-4-[4-[4-(4-HYDROXYPHENYL) -1-PIPERAZINYL]PHENYL]- 3H-1,2,4-TRIAZOL-3-ONE (POSACONAZOLE INTERMEDIATE POB)
01 1China
01 1Active
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33194
Submission : 2018-10-09
Status : Active
Type : II
20
Brightgene Bio-medical Technology Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is 2-[(1S,2S)-1-ETHY1-2-BEZYLOXYPROPYL]-2,4-DIHYDRO-4-[4-[4-(4-HYDROXYPHENYL) -1-PIPERAZINYL]PHENYL]- 3H-1,2,4-TRIAZOL-3-ONE (POSACONAZOLE INTERMEDIATE POB), with a corresponding US DMF Number 33194.
Remarkably, this DMF maintains an Active status since its submission on October 09, 2018, highlighting commitment to regulatory compliance.
